Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 196

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction

Rebola, Nelson, Simões, Ana Patrícia, Canas, Paula M., Tomé, Angelo R., Andrade, Geanne M., Barry, Claire E., Agostinho, Paula M., Lynch, Marina A., Cunha, Rodrigo A.·2011·Journal of Neurochemistry

Abstract

J. Neurochem. (2011) 117, 100–111. The blockade of adenosine A 2A receptors (A2AR) affords a robust neuroprotection in different noxious brain conditions. However, the mechanisms underlying this general neuroprotection are unknown. One possible mechanism could be the control of neuroinflammation that is associated with brain damage, especially because A2AR efficiently control peripheral inflammation. Thus, we tested if the intracerebroventricular injection of a selective A2AR antagonist (SCH58261) would attenuate the changes in the hippocampus triggered by intraperitoneal administration of lipopolysaccharide (LPS) that induces neuroinflammation through microglia activation. LPS administration triggers an increase in inflammatory mediators like interleukin‐1β that causes biochemical changes (p38 and c‐jun N‐terminal kinase phosphorylation and caspase 3 activation) contributing to neuronal dysfunction typified by decreased long‐term potentiation, a form of synaptic plasticity. Long‐term potentiation, measured 30 min after the tetanus, was significantly lower in LPS‐treated rats compared with control‐treated rats, while SCH58261 attenuated the LPS‐induced change. The LPS‐induced increases in phosphorylation of c‐jun N‐terminal kinase and p38 and activation of caspase 3 were also prevented by SCH58261. Significantly, SCH58261 also prevented the LPS‐induced recruitment of activated microglial cells and the increase in interleukin‐1β concentration in the hippocampus, indicating that A2AR activation is a pivotal step in mediating the neuroinflammation triggered by LPS. These results indicate that A2AR antagonists prevent neuroinflammation and support the hypothesis that this mechanism might contribute for the ability of A2AR antagonists to control different neurodegenerative diseases known to involve neuroinflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2011.07178.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 196

Metadata

Authors
Rebola, N., Simões, A. P., Canas, P. M., Tomé, A. R., Andrade, G. M., Barry, C. E., Agostinho, P. M., Lynch, M. A., & Cunha, R. A.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2011-02-09
Volume
117
Issue
1
Pages
100-111
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1593543865
Cited by
196
References
3
FWCI
5.04
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction. https://app.cochat.ai/papers/10.1111/j.1471-4159.2011.07178.x
The paper
Rebola, N., Simões, A. P., Canas, P. M., Tomé, A. R., Andrade, G. M., Barry, C. E., Agostinho, P. M., Lynch, M. A., & Cunha, R. A. (2011). Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2011.07178.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.